AIM: Patients with advanced cancer need information about end-of-life treatment options in order to make informed decisions. Clinicians vary in the frequency with which they initiate these discussions. PATIENTS AND METHODS: As part of a long-term longitudinal study, patients with an expected 2-year survival of less than 50% who had advanced gastrointestinal or lung cancer or amyotrophic lateral sclerosis (ALS) were interviewed. Each patient's medical record was reviewed at enrollment and at 3 months for evidence of the discussion of patient wishes concerning ventilator support, artificial nutrition and hydration (ANH), resuscitation (DNR) and hospice care. A Kaplan-Meier analysis was also performed and 2-year survival calculated. RESULTS: 60 cancer and 32 ALS patients were enrolled. ALS patients were more likely than cancer patients to have evidence of discussion about their wishes for ventilator support (31% vs 0%, p<0.001), ANH (38% vs 0%, p<0.001), DNR (25% vs 0%, p<0.001) and hospice care (22% vs 5%, p = 0.03). At 6 months, 91% of ALS patients were alive compared with 62% of cancer patients; at 2 years, 63% of ALS patients were alive compared with 23% of cancer patients (p<0.001). CONCLUSIONS: Cancer patients were less likely than ALS patients to have had documented advanced care planning discussions despite worse survival. This may reflect perceptions that ALS has a more predictable course, that advanced cancer has a greater number of treatment options, or differing views about hope. Nevertheless, cancer patients may be less adequately prepared for end-of-life decision-making.
AIM: Patients with advanced cancer need information about end-of-life treatment options in order to make informed decisions. Clinicians vary in the frequency with which they initiate these discussions. PATIENTS AND METHODS: As part of a long-term longitudinal study, patients with an expected 2-year survival of less than 50% who had advanced gastrointestinal or lung cancer or amyotrophic lateral sclerosis (ALS) were interviewed. Each patient's medical record was reviewed at enrollment and at 3 months for evidence of the discussion of patient wishes concerning ventilator support, artificial nutrition and hydration (ANH), resuscitation (DNR) and hospice care. A Kaplan-Meier analysis was also performed and 2-year survival calculated. RESULTS: 60 cancer and 32 ALSpatients were enrolled. ALSpatients were more likely than cancerpatients to have evidence of discussion about their wishes for ventilator support (31% vs 0%, p<0.001), ANH (38% vs 0%, p<0.001), DNR (25% vs 0%, p<0.001) and hospice care (22% vs 5%, p = 0.03). At 6 months, 91% of ALSpatients were alive compared with 62% of cancerpatients; at 2 years, 63% of ALSpatients were alive compared with 23% of cancerpatients (p<0.001). CONCLUSIONS:Cancerpatients were less likely than ALSpatients to have had documented advanced care planning discussions despite worse survival. This may reflect perceptions that ALS has a more predictable course, that advanced cancer has a greater number of treatment options, or differing views about hope. Nevertheless, cancerpatients may be less adequately prepared for end-of-life decision-making.
Authors: R G Miller; J A Rosenberg; D F Gelinas; H Mitsumoto; D Newman; R Sufit; G D Borasio; W G Bradley; M B Bromberg; B R Brooks; E J Kasarskis; T L Munsat; E A Oppenheimer Journal: Neurology Date: 1999-04-22 Impact factor: 9.910
Authors: Rebecca G Hagerty; Phyllis N Butow; Peter M Ellis; Elizabeth A Lobb; Susan C Pendlebury; Natasha Leighl; Craig MacLeod; Craig Mac Leod; Martin H N Tattersall Journal: J Clin Oncol Date: 2005-02-20 Impact factor: 44.544
Authors: Daniel P Sulmasy; Mark T Hughes; Gayane Yenokyan; Joan Kub; Peter B Terry; Alan B Astrow; Julie A Johnson; Grace Ho; Marie T Nolan Journal: J Pain Symptom Manage Date: 2017-07-14 Impact factor: 3.612
Authors: Eefje M Sizoo; H Roeline W Pasman; Linda Dirven; Christine Marosi; Wolfgang Grisold; Günther Stockhammer; Jonas Egeter; Robin Grant; Susan Chang; Jan J Heimans; Luc Deliens; Jaap C Reijneveld; Martin J B Taphoorn Journal: Support Care Cancer Date: 2013-12-14 Impact factor: 3.603
Authors: Nancy E Morden; Chiang-Hua Chang; Joseph O Jacobson; Ethan M Berke; Julie P W Bynum; Kimberly M Murray; David C Goodman Journal: Health Aff (Millwood) Date: 2012-04 Impact factor: 6.301
Authors: Lena Saltbaek; Hanne M Michelsen; Knud M Nelausen; Rikke Gut; Dorte L Nielsen Journal: Support Care Cancer Date: 2013-08-08 Impact factor: 3.603
Authors: Grace W K Ho; Lauren Skaggs; Gayane Yenokyan; Anela Kellogg; Julie A Johnson; Mei Ching Lee; Katherine Heinze; Mark T Hughes; Daniel P Sulmasy; Joan Kub; Peter B Terry; Alan B Astrow; Jing Zheng; Lisa Soleymani Lehmann; Marie T Nolan Journal: Palliat Support Care Date: 2016-05-30
Authors: Karen J Ortiz-Ortiz; Guillermo Tortolero-Luna; Carlos R Torres-Cintrón; Diego E Zavala-Zegarra; Axel Gierbolini-Bermúdez; María R Ramos-Fernández Journal: JCO Oncol Pract Date: 2021-02